According to the recent report published by Research Corridor, the Global Surgical Robots Market is expected to provide sustainable growth opportunities during the forecast period from 2020 to 2027. This latest industry research study analyzes the Surgical Robots market by various product segments, applications, regions and countries while assessing regional performances of numerous leading market participants.
The global surgical robot market size is anticipated to register a higher CAGR of around 22% during the forecast period 2021 to 2027 and was valued at over USD 2 billion in 2020. The rising adoption of minimally invasive surgeries due to benefits associated with it such as cost-effective and shorter hospital stay is a major factor to drive the market growth. The increasing interest of some major players and technological advancement is further expected to boost the market growth. Moreover, the rising adoption of robot-assisted surgeries and continuous research and development in robotic surgeries is projected to uplift the market over the forecast period.
The report titled "Surgical Robots Market - Global Trends, Market Share, Industry Size, Growth, Opportunities, and Forecast - 2020 – 2027" offers a holistic view of the Surgical Robots industry encompassing numerous stakeholders including raw material suppliers, providers, distributors, consumers and government agencies, among others. Furthermore, the report includes detailed quantitative and qualitative analysis of the global Surgical Robots market considering market history, product development, regional dynamics, competitive landscape, and key success factors (KSFs) in the industry.
Browse Full report on Global Surgical Robots Market report at: https://www.researchcorridor.com/surgical-robots-market//
The report includes a deep-dive analysis of key countries including the U.S., Canada, the U.K., Germany, France, China, Japan, India, Australia, Mexico, Brazil and South Africa, among others. Thereby, the report identifies unique growth opportunities across the world based on trends occurring in various developed and developing economies.
Surgical Robots Market report summarizes the positive growth rate in upcoming years, and market size with competitive analysis. Our experts have analyzed the historical data to compare with the current market scenario to calculate the market growth in the coming years. The study provides an exhaustive report that includes an executive summary, scope, and forecast of the market.
The Data Surgical Robots Market Segmentation:
By Application:
- Gynecological Surgery
- Urological Surgery
- Neurosurgery
- Orthopedic Surgery
- Others
By End-Use:
- Hospitals
- Ambulatory Surgery Centers (ASCs)
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
To know more about the study, make an inquiry before purchase @ https://www.researchcorridor.com/inquiry/?id=41315/
List of Key Companies:
- Smith and Nephew
- Medrobotics Corporation
- Intuitive Surgical
- TransEnterix, Inc.
- Medtronic
- Renishaw, plc
- Stryker Corporation
- Zimmer Biomet
- Think Surgical, Inc.
Key Questions Answered by Surgical Robots Market Report
- Product popularity and adoption based on various country-level dynamics
- Regional presence and product development for leading market participants
- Market forecasts and trend analysis based on ongoing investments and economic growth in key countries
- Competitive landscape based on revenue, product offerings, years of presence, number of employees and market concentration, among others
- number of employees and market concentration, among others
To know more about this study, request a free sample report @ https://www.researchcorridor.com/request-sample/?id=41315/
About Us:
Research Corridor is a global market research firm. Our insightful analysis is focused on developed and emerging markets. We identify trends and forecast markets with a view to aid businesses identify market opportunities optimize strategies. Our expert’s team of analysts provides enterprises with strategic insights. Research Corridor works to help enterprises grow through strategic insights and actionable solutions. Feel free to contact us for any report customization at [email protected] .
Media Contact:
Company Name: Research Corridor
Contact Person: Mr. Vijendra Singh
Email: [email protected]
Contact no: +1 520-686-7060
Visit us: https://www.researchcorridor.com/
The Spirulina Market is expected to grow at a CAGR of 10.3% from 2020-2030, according to a new research report by Next Move Strategy ConsultingSpirulina is a blue green algae with high nutrient content, usually consumed by human & animals.
It is also used as a complementary diet ingredient in aquaculture & poultry feeds owing to the presence of high protein & vitamin content.According to the report, growth in health consciousness among people and the rising demand for dietary supplements are major factors driving the spirulina market growth.
Additionally, high penetration of spirulina in industries such as cosmetics and pharmaceutical owing to the advantageous properties such as anti-aging, anti-wrinkles and othersare bringing changes in market tends.However, low stability & poor sustainability of spirulina derived colours is expected to restrict the market growth.Moreover, growth in research & development activities followed by untapped market opportunities in developing economies are anticipated to provide numerous opportunities to the market players in the coming few years.On the basis of type, spirulina market share is segmented into Arthrospira Platensis and Arthrospira Maxima.
Arthrospira Maxima dominates the global Spirulina market and will be the dominant throughout the forecasted period.On the basis of application, the Spirulina market is categorised into Nutraceuticals, Food & Beverages, Cosmetics, Animal Feed, and Others.Food & Beverages segment is likely to develop significantly over the period of time owing to fast growing food & beverage industry.On the basis of drug formulation, the spirulina market is bifurcated into Powder, Tablet & Capsule, Liquid, and Granule & Gelling Agent.
Powder segment is expected to account for the major market share & dominate the market growth over the forecast period.North America dominates the spirulina market in terms of market size over the forecast period, owing to rising health consciousness among people.
Hansen Holding A/S, Algenol Biofuels Inc., Dongtai City Spirulina Bio-engineering Co., Ltd., Prolgae, Parry Neutraceuticals, Sensient Technologies Corporation, DDW Inc., Algatec and Naturex S.A.Browse key industry insights from the report, “Spirulina Market Size By Type (ArthrospiraPlatensis and Arthrospira Maxima) By Application (Nutraceuticals, Food & Beverages, Cosmetics, Animal Feed, and Others), By Drug Formulation (Powder, Tablet & Capsule, Liquid, and Granule & Gelling Agent)Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Italy, Russia, China, India, Japan, Australia, Indonesia, Malaysia, South Korea, Brazil, Mexico, South Africa, Saudi Arabia, UAE, Kuwait), Growth Potential, Price Trends, Competitive Market Share & Forecast, 2020–2030” in detail along with the table of contents:Key Insights from the Spirulina Market Report:Asia Pacific is the fastest growing region in Spirulina market owing to the rising demand of spirulina from various industries such as cosmetics, food , healthcare and others and government initiatives to promote local spirulina production.The Food & Beverages segment dominates the market in terms of application and is expected to grow at a significant CAGR to maintain the lead till 2030.Some of the major players in the market are DIC Corporation, Cyanotech Corporation, Chr.
We have already seen and heard more about the impact of AI in different industries, like retail, logistics, healthcare, and so on.
Today we are going to discuss how AI is transforming the Pharmaceutical industry.
The use of technology in the pharma industry helps them to deliver safe and reliable drugs to market in time.
Statistics show that the biopharma market is projected to reach $10B BY 2024 (supplements101.ne).
The US and Asia is the largest pharmaceutical market globally.
New AI innovations, for example, Robotics and Microfluidics, blended in with Big Data Analytics, can fasten the drug development and approval process, thereby shortening the time to market frame.
There are variety of sizes we made available at our store.
Customers are offered to select according to their interior size.
Representatives can visit at your place to show you the samples, share ideas and take measurement.
This report studies the global market size of Pressure Infusion Cuffs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Pressure Infusion Cuffs in these regions.
This report also studies the global Pressure Infusion Cuffs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
Request a sample of this report@ https://www.orbisresearch.com/contacts/request-sample/2322852?utm_source=Mohit
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
AC Cossor & Son (Surgical)
Market size by End User
Non-Small Cell Lung Cancer Market is Expected to Increase With a CAGR of 10.7% for the Study Period of 2017-2030: DelveInsight (Albany, US) DelveInsight has introduced a new Market Insights, Epidemiology, and Market Forecast Report on "Non-Small Cell Lung Cancer Market Insights, Epidemiology, and Market Forecast-2030" to its portfolio.Key Highlights from report are:As per the DelveInsight analysis, the total incident cases of NSCLC in the 7MM were observed to be 484,726 cases in the year 2017.
These cases are expected to grow with a significant CAGR in the study period 2017–2030.There are different types of treatment available for NSCLC; however, mainly 10 types of standard treatment are used, which include Surgery, Radiation therapy, Chemotherapy, Targeted therapy, Immunotherapy, Laser therapy, Photodynamic therapy (PDT), Cryosurgery, Electrocautery, and Watchful waiting.The market size of NSCLC in the 7MM is expected to increase during study period.
According to the estimates, the highest contribution in the market size of NSCLC is from the United States followed by Japan, Germany, and the UK.One of the most exciting developments in lung cancer medicine is the introduction of targeted treatments.Request for free sample pages to know more on Non-Small Cell Lung Cancer Market Forecast NSCLC is the most common type of lung cancer accounted for approximately 85% of all lung cancers.
The disease epidemiology included in the report provides historical as well as forecasted Non-Small Cell Lung Cancer epidemiology, which is segmented as Total Incident cases of NSCLC patients, Total Incident cases of NSCLC patients by Histology, Total Diagnosed cases of NSCLC patients by Stages, Total NSCLC cases of patients by Genetic mutation/Biomarkers, and Total Treated Cases of NSCLC patients by Line of Therapies scenario of NSCLC in the 7MM.The total NSCLC incident cases in the 7MM were observed to be 484,726 cases in 2017.Click here to know more on Non-Small Cell Lung Cancer pipelineNSCLC report encloses the detailed analysis of Non-Small Cell Lung Cancer marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs.
The therapies that are approved for the NSCLC treatment are Rozlytrek (Entrectinib), Imfinzi (Durvalumab), Opdivo (Nivolumab), Tecentriq (Atezolizumab), Keytruda (Pembrolizumab), Tafinlar (Dabrafenib) in combination with Mekinist (Trametinib), Tagrisso (osimertinib), Lorbrena/Lorviqua (Lorlatinib), Vizimpro (Dacomitinib), Alunbrig (Brigatinib), Alecensa (Alectinib), Vitrakvi (Larotrectinib), Portrazza (Necitumumab) along with many more.Drugs covered in the report are:-There are several key players robustly involved in developing potential products such asNazartinib (EGF816)Capmatinib (INC280)Tepmetko (tepotinib)MerestinibJNJ-61186372 (JNJ-6372)Vemurafenib Plus CobimetinibX-396 (Ensartinib)Tedopi (OSE2101)Selpercatinib (LY3527723/ LOXO-292)SAR408701Braftovi (encorafinib) + Mektovi (binimetinib)PADCEV (enfortumab vedotin/ASG-22ME)Pralsetinib (BLU-667)TAK-788: Canakinumab (ACZ885)Avelumab (Bavencio)Veliparib (ABT-888): Sitravatinib (MGCD516)TesevatinibRomiplostim: CabozantinibSym015AMG 510INCMGA00012 (MGA012)Libtayo (Cemiplimab)BavituximabM7824 (Bintrafusp alfa)And many others Key Players covered in the report are:-Novartis PharmaceuticalsMerck KGaAEli Lilly and CompanyJanssen Research & DevelopmentHoffmann-La RocheXcoveryBeyondSpring PharmaceuticalsOSE ImmunotherapeuticsSanofiPfizerAstellas PharmaSeattle GeneticsBlueprint Medicines CorporationTakedaAbbVieKadmon CorporationAmgenSymphogenRegeneron PharmaceuticalsPeregrine PharmaceuticalsAvid BioservicesGlaxoSmithKlineAnd many othersThe report includes provides in depth analysis historical and forecasted Market Share (%) Distribution of NSCLC, Market Share (%) Distribution of NSCLC by Mutations/Biomarkers, Total Market Size of PD-L1 NSCLC, Total Market Size of BRAF NSCLC, Total Market Size of c-Met, Total Market Size of EGFR, Total Market Size of ALK as well.The reasons for buying this report:The report proffers an overview of pathophysiology, various diagnostic approaches and NSCLC treatment algorithm, including detailed chapters for marketed products and emerging therapies.Historical and forecasted Non-Small Cell Lung Cancer epidemiology in 7MM covering the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2017-2030.Detailed historical and forecasted NSCLC market covering the United States, EU5 and Japan from 2017-2030.
Pipeline analysis across different stages of development (Phase III and Phase II), different emerging trends and comparative analysis of pipeline products with comprehensive clinical profiles, key cross-competition, launch date along with product development activities.
The global M2M communication market is expected to exhibit a strong 10% CAGR over the forecast period from 2016 to 2022, according to the latest research report from Market Research Future (MRFR).
The report presents a detailed overview of the global M2M communication market’s historical and present growth trajectory, and makes accurate forecasts as to the market’s likely growth trajectory over the forecast period.
M2M communication is a suite of technologies by the use of which machines and sensors can relay data to each other, leading to corresponding actions in the machines.
The widespread applicability and functionality of IoT tools has led to widespread adoption of IoT technology in recent years, increasing the commercial scope for the global M2M communication market in the process.
Growing demand for IoT in various industrial sectors is likely to be a major driver for the global M2M communication market over the forecast period.
Blood glucose monitors are among the most common health monitors used across the world.
